Siemens Healthineers Forecasts 4-5% Revenue Growth for FY2027
Key Facts
Siemens Healthineers expects revenue growth of 4% to 5% for the fiscal year 2027. Reuters reported that the company issued this long-term guidance to provide investors with clarity regarding its growth expectations.
SMMNY closed at $25.32 on November 4, 2026, with the stock reaching a day high of $25.32 and a low of $24.96. The forecast reflects the company's outlook on its operational trajectory and future expansion within the healthcare sector.
Latest Updates · 2
- Major·
Update: Siemens Healthineers announced a 400 million EUR cost-cutting program for its diagnostics division on November 5, 2026. The initiative was unveiled alongside the company's Q4 2026 financial results as part of a broader effort to improve operational efficiency.
- Notable·
Update: Siemens Healthineers announced on November 5, 2026, the launch of a new restructuring program titled 'Transform4 Future'. The initiative is designed to cut costs and offset expenditures related to the carve-out of its diagnostics division.